Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes
Open Access
- 28 September 2016
- journal article
- research article
- Published by BMJ in Open Heart
- Vol. 3 (2), e000473
- https://doi.org/10.1136/openhrt-2016-000473
Abstract
Objectives Hypertension is well established as a major risk factor for cardiovascular disease. Although there is undeniable evidence to support the beneficial effects of antihypertensive therapy on morbidity and mortality, adequate blood pressure management still remains suboptimal. Research into the treatment of hypertension has produced a multitude of drug classes with different efficacy profiles. These agents include β-blockers, diuretics, ACE inhibitors, angiotensin receptor blockers and calcium channel blockers. One of the oldest groups of antihypertensives, the calcium channel blockers are a heterogeneous group of medications. Methods This review paper will focus on amlodipine, a dihydropyridine calcium channel blockers, which has been widely used for 2 decades. Results Amlodipine has good efficacy and safety, in addition to strong evidence from large randomised controlled trials for cardiovascular event reduction. Conclusions Amlodipine should be considered a first-line antihypertensive agent.Keywords
This publication has 41 references indexed in Scilit:
- Telmisartan and Amlodipine Single-Pill Combinations vs Amlodipine Monotherapy for Superior Blood Pressure Lowering and Improved Tolerability in Patients With Uncontrolled Hypertension: Results of the TEAMSTA-5 StudyThe Journal of Clinical Hypertension, 2011
- Triple Antihypertensive Therapy With Amlodipine, Valsartan, and HydrochlorothiazideHypertension, 2009
- An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: The assessment of combination therapy of amlodipine/ramipril (ATAR) studyClinical Therapeutics, 2008
- Effect of Losartan and Amlodipine on Left Ventricular Diastolic Function in Patients With Mild-to-Moderate Hypertension (J-ELAN) Rationale and DesignCirculation Journal, 2006
- Calcium Channel Blockades Exhibit Anti-Inflammatory and Antioxidative Effects by Augmentation of Endothelial Nitric Oxide Synthase and the Inhibition of Angiotensin Converting Enzyme in the NG-Nitro-L-Arginine Methyl Ester-Induced Hypertensive Rat Aorta: Vasoprotective Effects beyond the Blood Pressure-Lowering Effects of Amlodipine and ManidipineHypertension Research, 2005
- Guidelines for Antihypertensive TreatmentJournal of the American Society of Nephrology, 2004
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Effect of amlodipine on mode of death among patients with advanced heart failure in the praise trialThe American Journal of Cardiology, 1998
- Usefulness of amlodipine for angina pectorisThe American Journal of Cardiology, 1994
- Pharmacokinetics and Pharmacodynamics of AmlodipineCardiology, 1992